Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Jun 21, 2023; 29(23): 3658-3667
Published online Jun 21, 2023. doi: 10.3748/wjg.v29.i23.3658
Table 2 Prognosis outcomes in the serum and glucocorticoid-induced protein kinase 3 normal and overexpression groups
Prognosis factors, n (%)
SGK3 normal, n = 37
SGK3 overexpression, n = 55
P value
Tumor recurrence1, n (%)0.306
    Present2 (5.4)8 (14.5)
    Absent35 (94.6)47 (85.5)
Metastasis1, n (%)0.402
    Present1 (2.7)0 (0)
    Absent36 (97.3)55 (100)
Death1, n (%)0.031
    Yes3 (8.1)15 (27.3)
    No34 (91.9)40 (72.7)